drugset / Trial / NCT00699413
Supplements for Controlling Resistance to Insulin
Phase 4
Terminated
8 enrolled
University of Southern California
InterHealth Nutraceuticals, Inc. · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participants will be evaluated with regard to BMI, percent body fat, insulin activity, and hunger.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-08
- Completion
- 2008-08
Outcome
Outcome not reported
Stopped: “Sponsor decided to withdraw from study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | hydroxycitrate | Unknown | 2700 mg | — |
| Comparator | niacin-bound Chromium | Unknown | 400 ug | — |